|
Mechanism50S subunit inhibitors [+4] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date25 Feb 2016 |
|
Mechanism50S subunit inhibitors [+2] |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date15 Aug 2013 |
|
Mechanism50S subunit inhibitors [+2] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc.US |
First Approval Date02 Dec 1997 |
The Effect of Propolis and Nutritional Education in Patients With H. Pylori on Gastrointestinal Symptoms
This research aims to contribute to the literature by researching the effect of propolis as an add-on treatment and nutritional education on patients with H pylori and the alleviation of gastrointestinal symptoms.In order to achieve this, we offered propolis and educational nutrion programme to our 96 patients and check on their symptoms on a regular basis to note any improvement by measuring the alleviation using GSRS.
14-day PCAB-based and Reverse Hybrid Therapy Fro Helicobacter Pylori
Test for Helicobacter pylori. The test items include urease test, histology, bacterial culture, serology, and urea breath test. At least two positive results can be used to confirm the diagnosis.
To ensure that the research results are not artificially distorted, this trial is a randomized study. Random allocation (which means that the subjects will use the "random number table generated by a computer similar to the lottery" to determine the treatment group) accept one of the following schemes (1:1:1).
100 Clinical Results associated with PBPs x 50S subunit
100 Translational Medicine associated with PBPs x 50S subunit
0 Patents (Medical) associated with PBPs x 50S subunit